Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01491763
Title Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE
Recruitment Unknown status
Gender both
Phase FDA approved
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | child
Covered Countries ESP


No variant requirements are available.